0000000000649311

AUTHOR

A. Sinclair

showing 2 related works from this author

Association between sarcopenia and diabetes: a systematic review and meta-analysis of observational studies

2019

To summarize the prevalence of diabetes in people with sarcopenia (and vice versa) through a meta-analytic approach of available observational studies. In this work, we have presented the findings of the first full methodological systematic review and meta-analysis of observational studies exploring the relationship between diabetes and sarcopenia. Our findings overall emphasize the reciprocal relationship between diabetes and sarcopenia in terms of risk of occurrence, that is sarcopenia increases the risk of diabetes being present and vice versa. This study provides support for further research into the prognosis of people with both diabetes and sarcopenia and the value of interventional s…

medicine.medical_specialtySarcopeniaDiabetePhysical performance03 medical and health sciences0302 clinical medicineInsulin resistancesystematic reviewInternal medicineDiabetes mellitusmedicine030212 general & internal medicine030214 geriatricsbusiness.industryConfoundingDiabetesOdds ratiomusculoskeletal systemmedicine.diseaseConfidence intervalbody regionsMeta-analysisSarcopeniaMeta-analysisObservational studybusinesshuman activities
researchProduct

Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-contro…

2019

Introduction Non-invasive vagus nerve stimulation (nVNS; gammaCore®) has the potential to prevent migraine days in patients with migraine on the basis of mechanistic rationale and pilot clinical data. Methods This multicentre study included a 4-week run-in period, a 12-week double-blind period of randomised treatment with nVNS or sham, and a 24-week open-label period of nVNS. Patients were to administer two 120-second stimulations bilaterally to the neck three times daily (6–8 hours apart). Results Of 477 enrolled patients, 332 comprised the intent-to-treat (ITT) population. Mean reductions in migraine days per month (primary outcome) were 2.26 for nVNS (n = 165; baseline, 7.9 days) and 1.8…

AdultMaleVagus Nerve StimulationMigraine DisordersMigraine prophylaxismedicine.medical_treatmentMedizinlaw.inventionDouble blindvagal activation03 medical and health sciences0302 clinical medicineDouble-Blind MethodEpisodic migraineRandomized controlled triallawHumanspreventive therapyMedicineIn patient030304 developmental biologymigraine prophylaxis0303 health sciencesNeuromodulationbusiness.industryNon invasiveNon-pharmacologic treatmentOriginal ArticlesGeneral MedicineMiddle Agedmedicine.diseaseNeuromodulation (medicine)3. Good healthTreatment OutcomeMigrainenon-pharmacologic treatmentAnesthesiaVagal activationFemaleNeurology (clinical)Preventive therapybusinessRCT030217 neurology & neurosurgeryVagus nerve stimulationCephalalgia
researchProduct